Jeff Landau

2021

In 2021, Jeff Landau earned a total compensation of $1.8M as Senior Vice President and Chief Business Officer at CytomX Therapeutics.

Compensation breakdown

Bonus$115,000
Non-Equity Incentive Plan$112,688
Option Awards$1,127,559
Salary$274,924
Stock Awards$120,150
Other$5,000
Total$1,755,321

Landau received $1.1M in option awards, accounting for 64% of the total pay in 2021.

Landau also received $115K in bonus, $112.7K in non-equity incentive plan, $274.9K in salary, $120.2K in stock awards and $5K in other compensation.

Rankings

In 2021, Jeff Landau's compensation ranked 6,569th out of 12,415 executives tracked by ExecPay. In other words, Landau earned more than 47.1% of executives.

ClassificationRankingPercentile
All
6,569
out of 12,415
47th
Division
Manufacturing
2,829
out of 5,505
49th
Major group
Chemicals And Allied Products
1,246
out of 2,375
48th
Industry group
Drugs
1,111
out of 2,096
47th
Industry
Pharmaceutical Preparations
806
out of 1,546
48th
Source: SEC filing on April 27, 2023.

Landau's colleagues

We found five more compensation records of executives who worked with Jeff Landau at CytomX Therapeutics in 2021.

2021

Sean McCarthy

CytomX Therapeutics

Chief Executive Officer

2021

Amy Peterson

CytomX Therapeutics

Chief Operating Officer

2021

Alison Hannah

CytomX Therapeutics

Chief Medical Officer

2021

Lloyd Rowland

CytomX Therapeutics

General Counsel

2021

Carlos Campoy

CytomX Therapeutics

Chief Financial Officer

News

In-depth

You may also like